Workflow
应用创新
icon
Search documents
两张应用场景清单拓宽创新大门
Shen Zhen Shang Bao· 2025-07-07 22:47
Core Viewpoint - The release of the "demand list" and "capability list" by the Shenzhen Development and Reform Commission aims to stimulate innovation and address both existing and potential new demands in various sectors, including emergency response, low-altitude economy, and healthcare [1][2]. Group 1: Demand and Capability Lists - The demand list includes 67 open application scenarios across 17 fields, while the capability list features 140 new technologies, products, and solutions from top universities and high-level research institutions [1]. - The dual-list approach is designed to clarify known demands and showcase available innovative tools, encouraging enterprises to develop new applications and meet previously unidentified needs [1][2]. Group 2: Impact on Innovation and Enterprises - The capability list serves as a platform for small and medium-sized enterprises to leverage existing technologies for their own market development, thus lowering the barriers to innovation [2]. - Shenzhen has a history of application innovation, exemplified by companies like DJI, which expanded its drone technology into various sectors, demonstrating the potential of application innovation in driving economic growth [2]. - The city's commitment to providing application scenarios facilitates the bridging of technology innovation and commercial application, transforming the city into a testing ground for new technologies and products [2].
港股科技50ETF(513980)涨近2%,成交额超5亿元!依然看好港股相对全球市场的收益表现
Jin Rong Jie· 2025-06-09 05:18
Group 1 - The core viewpoint of the articles highlights a positive trend in the Hong Kong stock market, particularly in technology and pharmaceutical sectors, with significant gains observed in the Hong Kong Technology 50 ETF and various individual stocks [1][2] - The Hong Kong Technology 50 ETF (513980) has seen a year-to-date increase of over 32%, with a recent trading volume of 5.07 billion yuan and a net inflow of 62.05 billion yuan since the beginning of the year [1] - Major stocks in the innovation drug sector have shown strong performance, with notable increases such as Genscript Biotech rising over 14% and 3SBio increasing over 7% [1] Group 2 - According to Huatai Securities, the recent positive signals from the US-China summit may reduce tariff friction, potentially enhancing China's growth expectations and providing upward momentum for the renminbi and its assets [1] - Industrial growth is anticipated to focus on technology, particularly the AI industry chain, with an emphasis on upstream computing power and downstream application innovation [2] - The Hong Kong Technology 50 ETF is the largest in its category, with a fund size of 135.99 billion yuan, reflecting the performance of leading companies in internet, new energy vehicles, and biomedicine sectors [2]